1) Quigley JC, Hart WR:Adenomatoid tumors of the uterus. Am J Clin Pathol 76:627-635, 1981
2) Nogales FF, Isaac MA, Hardisson D, et al:Adenomatoid tumors of the uterus. An analysis of 60 cases. Int J Gynecol Pathol 21:34-40, 2001
3) Shintaku M, Sasaki M, Honda T:Thrombomodulin immunoreactivity in adenomatoid tumour of the uterus. Histopathology 28:375-377, 1996
4) Doglioni C, Dei Tos AP, Laurino L, et al:Calretinin. A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20:1037-1046, 1996
5) Delahunt B, Eble JN, Srigley JR, et al:Paratesticular adenomatoid tumor. Assessment of calretinin immunoexpression and cell proliferation indices. J Urol Pathol 12:105-115, 2000
6) Breiteneder-Geleff S, Soleiman A, Kowalski H, et al:Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385-394, 1999
7) Schacht V, Dadras SS, Johnson LA, et al:Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166:913-921, 2005
8) Kimura N, Kimura I:Podoplanin as a marker for mesothelioma. Pathol Int 55:83-86, 2005
9) Chu AY, Litzky LA, Pasha TL, et al:Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105-110, 2005
10) Hamamatsu A, Arai T, Iwamoto M, et al:Adenomatoid tumor of the adrenal gland. Case report with immunohistochemical study. Pathol Int 55:665-669, 2005